Close

"CF Sales Trajectory is Sufficiently Reflected in the Stock at Current Levels" - Needham & Company Maintains Vertex (VRTX) at Hold May 6, 2022 06:42AM
Needham & Company Downgrades Vertex (VRTX) to Hold Aug 1, 2019 07:06AM
Pre-Open Stock Movers 04/16: (ELF) (CRSP) (GH) Higher; (BRS) (WVE) (IP) Lower (more...) Apr 16, 2019 09:29AM
Vertex Pharma (VRTX): Remain Focused On Triple - Needham Oct 26, 2017 07:33AM
Vertex (VRTX) PT Raised to $195 at Needham & Company Following Triple Combo Data Jul 19, 2017 06:57AM
View Older Stories

Jun 23, 2017 06:54AM Needham & Company Upgrades Vertex (VRTX) to Buy Ahead of CF Triple Regimen Data
May 13, 2015 08:19AM Vertex (VRTX) Success Already Priced in the Stock, Needham & Company Says
Jan 29, 2015 07:54AM Needham & Company Downgrades Vertex (VRTX) to Hold
Jun 24, 2014 12:46PM Vertex (VRTX) PT Raised to $115 at Needham & Company
Jun 4, 2014 10:08AM Needham & Company Discusses Vertex (VRTX) Phase 2 Trial of Ivacaftor in CF
May 2, 2014 07:41AM Vertex (VRTX) Bullish Stance Reiterated at Needham & Company after Q1 Results, Encouraging VX-661-Ivacaftor Phase 2 Data
Dec 19, 2013 09:30AM Pre-Open Stock Movers 12/19: (ALIM) (AKS) (ORCL) Higher; (CIE) (GIG) (FB) Lower (more...)
Oct 21, 2013 07:29AM Vertex (VRTX) Bullish Stance Maintained after NACFC - Needham & Company
Jul 30, 2013 09:07AM Needham & Company Maintains Bullish View on Vertex (VRTX) Following Q2 Earnings
Jul 26, 2013 08:18AM Needham & Company Keeps Buy on Vertex (VRTX) Despite Partial Clinical Hold
Apr 19, 2013 07:25AM Vertex (VRTX) PT Goes to $95 at Needham & Company after Strong Data
Oct 12, 2012 08:29AM Analyst Says Vertex (VRTX) Drug Data Shows "At Least Moderate Impact"
Jul 31, 2012 08:31AM Needham & Company Reiterates a 'Buy' on Vertex (VRTX); Incivek Sales Continue to Fall, But Initial ALS-2200 Data Are Encouraging
Jul 18, 2012 01:10PM Needham & Company Maintains a 'Buy' on Vertex (VRTX); Adjusting Q2 Lower, But Positive on Cash Flow
Jun 29, 2012 08:16AM Needham & Company Reiterates a 'Buy' on Vertex (VRTX); Combination Trial in CF Encouraging
May 29, 2012 10:35AM Needham & Company Maintains Bullish Stance on Vertex (VRTX) Despite Weaker Data
May 8, 2012 11:02AM Notable Analyst Rating Changes 05/08: (VRTX) (XCO) (EA) Upgraded; (EP) (BP) (AMX) Downgraded
May 8, 2012 08:00AM Needham & Company Upgrades Vertex (VRTX) to Buy; Positive Interim VX-809/Kalydeco Results; Large Market Opp
Apr 17, 2012 07:40AM Needham & Company Maintains a 'Hold' on Vertex (VRTX); Q1 Preview
Jan 31, 2012 04:12PM Needham & Company Maintains a 'Hold' on Vertex (VRTX); Surprisingly Early Approval of Kalydeco for G551D Cystic Fibrosis
Dec 23, 2011 07:35AM Needham & Company 2012 Biotech Preview
Nov 8, 2011 09:15AM Needham & Company Maintains a 'Hold' on Vertex (VRTX); AASLD Meeting Update
Oct 28, 2011 08:46AM Needham & Company Maintains a 'Hold' on Vertex (VRTX); Incivek Sales Exceed Expectations Again, But Growth Appears to Be Slowing
Sep 22, 2011 04:40PM Needham & Company Maintains a 'Hold' on Vertex (VRTX); Raising Incivek Sales Estimates, But Concerns Remain
May 26, 2011 11:15AM Notable Analyst Rating Changes 05/26: (HST) (FITB) (CTSH) Upgraded; (RSH) (LULU) (CAVM) Downgraded
May 4, 2011 09:14AM Needham & Company Maintains a 'Hold' on Vertex (VRTX); 1Q11 Review; Vertex Ready for Incivek Approval and Launch
Apr 29, 2011 10:25AM Needham & Company Maintains a 'Hold' on Vertex (VRTX); Telaprevir Gets Enthusiastic Endorsement from FDA Advisory Committee, But Concerns Remain
Feb 23, 2011 12:33PM Needham & Company Maintains a 'Hold' on Vertex (VRTX); Positive VX-770 Phase 3 Outcome in CF, But High Investor Expectations for HCV Program
Sep 8, 2010 02:52PM Needham & Company Downgraded Vertex (VRTX) to Hold
May 26, 2010 07:39AM Needham & Company Reiterates a 'Buy' on Vertex Pharmaceuticals (VRTX); Encouraging Top-Line Results from Phase 3 ADVANCE Trial
Apr 22, 2010 07:57AM Needham & Company Reiterates a 'Buy' on Vertex Pharmaceuticals (VRTX); Room for Upside Around Phase 3 ADVANCE Results
Jan 12, 2010 08:42AM Needham & Co Reiterates a 'Buy' on Vertex Pharmaceuticals (VRTX); Raises Price Target
Sep 26, 2008 08:52AM Needham & Co Upgrades Vertex Pharmaceuticals (VRTX) to Buy
View Older Stories